Follicular Lymphoma Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Follicular Lymphoma Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Follicular Lymphoma Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Follicular Lymphoma Treatment Overall Market Size
2.1 Global Follicular Lymphoma Treatment Market Size: 2021 VS 2028
2.2 Global Follicular Lymphoma Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Follicular Lymphoma Treatment Players in Global Market
3.2 Top Global Follicular Lymphoma Treatment Companies Ranked by Revenue
3.3 Global Follicular Lymphoma Treatment Revenue by Companies
3.4 Top 3 and Top 5 Follicular Lymphoma Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Follicular Lymphoma Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Follicular Lymphoma Treatment Players in Global Market
3.6.1 List of Global Tier 1 Follicular Lymphoma Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Follicular Lymphoma Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Follicular Lymphoma Treatment Market Size Markets, 2021 & 2028
4.1.2 Chemotherapy
4.1.3 Radiotherapy
4.1.4 Monoclonal Antibodies
4.1.5 Stem Cell Transplantation
4.2 By Type - Global Follicular Lymphoma Treatment Revenue & Forecasts
4.2.1 By Type - Global Follicular Lymphoma Treatment Revenue, 2017-2022
4.2.2 By Type - Global Follicular Lymphoma Treatment Revenue, 2023-2028
4.2.3 By Type - Global Follicular Lymphoma Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Follicular Lymphoma Treatment Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Follicular Lymphoma Treatment Revenue & Forecasts
5.2.1 By Application - Global Follicular Lymphoma Treatment Revenue, 2017-2022
5.2.2 By Application - Global Follicular Lymphoma Treatment Revenue, 2023-2028
5.2.3 By Application - Global Follicular Lymphoma Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Follicular Lymphoma Treatment Market Size, 2021 & 2028
6.2 By Region - Global Follicular Lymphoma Treatment Revenue & Forecasts
6.2.1 By Region - Global Follicular Lymphoma Treatment Revenue, 2017-2022
6.2.2 By Region - Global Follicular Lymphoma Treatment Revenue, 2023-2028
6.2.3 By Region - Global Follicular Lymphoma Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Follicular Lymphoma Treatment Revenue, 2017-2028
6.3.2 US Follicular Lymphoma Treatment Market Size, 2017-2028
6.3.3 Canada Follicular Lymphoma Treatment Market Size, 2017-2028
6.3.4 Mexico Follicular Lymphoma Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Follicular Lymphoma Treatment Revenue, 2017-2028
6.4.2 Germany Follicular Lymphoma Treatment Market Size, 2017-2028
6.4.3 France Follicular Lymphoma Treatment Market Size, 2017-2028
6.4.4 U.K. Follicular Lymphoma Treatment Market Size, 2017-2028
6.4.5 Italy Follicular Lymphoma Treatment Market Size, 2017-2028
6.4.6 Russia Follicular Lymphoma Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Follicular Lymphoma Treatment Market Size, 2017-2028
6.4.8 Benelux Follicular Lymphoma Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Follicular Lymphoma Treatment Revenue, 2017-2028
6.5.2 China Follicular Lymphoma Treatment Market Size, 2017-2028
6.5.3 Japan Follicular Lymphoma Treatment Market Size, 2017-2028
6.5.4 South Korea Follicular Lymphoma Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Follicular Lymphoma Treatment Market Size, 2017-2028
6.5.6 India Follicular Lymphoma Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Follicular Lymphoma Treatment Revenue, 2017-2028
6.6.2 Brazil Follicular Lymphoma Treatment Market Size, 2017-2028
6.6.3 Argentina Follicular Lymphoma Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Follicular Lymphoma Treatment Revenue, 2017-2028
6.7.2 Turkey Follicular Lymphoma Treatment Market Size, 2017-2028
6.7.3 Israel Follicular Lymphoma Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Follicular Lymphoma Treatment Market Size, 2017-2028
6.7.5 UAE Follicular Lymphoma Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Boehringer Ingelheim GmbH
7.1.1 Boehringer Ingelheim GmbH Corporate Summary
7.1.2 Boehringer Ingelheim GmbH Business Overview
7.1.3 Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Major Product Offerings
7.1.4 Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Revenue in Global Market (2017-2022)
7.1.5 Boehringer Ingelheim GmbH Key News
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Corporate Summary
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company Follicular Lymphoma Treatment Major Product Offerings
7.2.4 Bristol-Myers Squibb Company Follicular Lymphoma Treatment Revenue in Global Market (2017-2022)
7.2.5 Bristol-Myers Squibb Company Key News
7.3 Celgene Corporation
7.3.1 Celgene Corporation Corporate Summary
7.3.2 Celgene Corporation Business Overview
7.3.3 Celgene Corporation Follicular Lymphoma Treatment Major Product Offerings
7.3.4 Celgene Corporation Follicular Lymphoma Treatment Revenue in Global Market (2017-2022)
7.3.5 Celgene Corporation Key News
7.4 Celldex Therapeutics, Inc.
7.4.1 Celldex Therapeutics, Inc. Corporate Summary
7.4.2 Celldex Therapeutics, Inc. Business Overview
7.4.3 Celldex Therapeutics, Inc. Follicular Lymphoma Treatment Major Product Offerings
7.4.4 Celldex Therapeutics, Inc. Follicular Lymphoma Treatment Revenue in Global Market (2017-2022)
7.4.5 Celldex Therapeutics, Inc. Key News
7.5 Celltrion, Inc.
7.5.1 Celltrion, Inc. Corporate Summary
7.5.2 Celltrion, Inc. Business Overview
7.5.3 Celltrion, Inc. Follicular Lymphoma Treatment Major Product Offerings
7.5.4 Celltrion, Inc. Follicular Lymphoma Treatment Revenue in Global Market (2017-2022)
7.5.5 Celltrion, Inc. Key News
7.6 Cellular Biomedicine Group, Inc.
7.6.1 Cellular Biomedicine Group, Inc. Corporate Summary
7.6.2 Cellular Biomedicine Group, Inc. Business Overview
7.6.3 Cellular Biomedicine Group, Inc. Follicular Lymphoma Treatment Major Product Offerings
7.6.4 Cellular Biomedicine Group, Inc. Follicular Lymphoma Treatment Revenue in Global Market (2017-2022)
7.6.5 Cellular Biomedicine Group, Inc. Key News
7.7 Coherus BioSciences, Inc.
7.7.1 Coherus BioSciences, Inc. Corporate Summary
7.7.2 Coherus BioSciences, Inc. Business Overview
7.7.3 Coherus BioSciences, Inc. Follicular Lymphoma Treatment Major Product Offerings
7.7.4 Coherus BioSciences, Inc. Follicular Lymphoma Treatment Revenue in Global Market (2017-2022)
7.7.5 Coherus BioSciences, Inc. Key News
7.8 CTI BioPharma Corp.
7.8.1 CTI BioPharma Corp. Corporate Summary
7.8.2 CTI BioPharma Corp. Business Overview
7.8.3 CTI BioPharma Corp. Follicular Lymphoma Treatment Major Product Offerings
7.8.4 CTI BioPharma Corp. Follicular Lymphoma Treatment Revenue in Global Market (2017-2022)
7.8.5 CTI BioPharma Corp. Key News
7.9 Curis, Inc.
7.9.1 Curis, Inc. Corporate Summary
7.9.2 Curis, Inc. Business Overview
7.9.3 Curis, Inc. Follicular Lymphoma Treatment Major Product Offerings
7.9.4 Curis, Inc. Follicular Lymphoma Treatment Revenue in Global Market (2017-2022)
7.9.5 Curis, Inc. Key News
7.10 Dynavax Technologies Corporation
7.10.1 Dynavax Technologies Corporation Corporate Summary
7.10.2 Dynavax Technologies Corporation Business Overview
7.10.3 Dynavax Technologies Corporation Follicular Lymphoma Treatment Major Product Offerings
7.10.4 Dynavax Technologies Corporation Follicular Lymphoma Treatment Revenue in Global Market (2017-2022)
7.10.5 Dynavax Technologies Corporation Key News
7.11 Eisai
7.11.1 Eisai Corporate Summary
7.11.2 Eisai Business Overview
7.11.3 Eisai Follicular Lymphoma Treatment Major Product Offerings
7.11.4 Eisai Follicular Lymphoma Treatment Revenue in Global Market (2017-2022)
7.11.5 Eisai Key News
7.12 EpiZyme, Inc.
7.12.1 EpiZyme, Inc. Corporate Summary
7.12.2 EpiZyme, Inc. Business Overview
7.12.3 EpiZyme, Inc. Follicular Lymphoma Treatment Major Product Offerings
7.12.4 EpiZyme, Inc. Follicular Lymphoma Treatment Revenue in Global Market (2017-2022)
7.12.5 EpiZyme, Inc. Key News
7.13 F. Hoffmann-La Roche Ltd.
7.13.1 F. Hoffmann-La Roche Ltd. Corporate Summary
7.13.2 F. Hoffmann-La Roche Ltd. Business Overview
7.13.3 F. Hoffmann-La Roche Ltd. Follicular Lymphoma Treatment Major Product Offerings
7.13.4 F. Hoffmann-La Roche Ltd. Follicular Lymphoma Treatment Revenue in Global Market (2017-2022)
7.13.5 F. Hoffmann-La Roche Ltd. Key News
7.14 Genentech, Inc.
7.14.1 Genentech, Inc. Corporate Summary
7.14.2 Genentech, Inc. Business Overview
7.14.3 Genentech, Inc. Follicular Lymphoma Treatment Major Product Offerings
7.14.4 Genentech, Inc. Follicular Lymphoma Treatment Revenue in Global Market (2017-2022)
7.14.5 Genentech, Inc. Key News
7.15 Gilead Sciences, Inc.
7.15.1 Gilead Sciences, Inc. Corporate Summary
7.15.2 Gilead Sciences, Inc. Business Overview
7.15.3 Gilead Sciences, Inc. Follicular Lymphoma Treatment Major Product Offerings
7.15.4 Gilead Sciences, Inc. Follicular Lymphoma Treatment Revenue in Global Market (2017-2022)
7.15.5 Gilead Sciences, Inc. Key News
7.16 GlaxoSmithKline Plc
7.16.1 GlaxoSmithKline Plc Corporate Summary
7.16.2 GlaxoSmithKline Plc Business Overview
7.16.3 GlaxoSmithKline Plc Follicular Lymphoma Treatment Major Product Offerings
7.16.4 GlaxoSmithKline Plc Follicular Lymphoma Treatment Revenue in Global Market (2017-2022)
7.16.5 GlaxoSmithKline Plc Key News
7.17 Hutchison MediPharma Limited
7.17.1 Hutchison MediPharma Limited Corporate Summary
7.17.2 Hutchison MediPharma Limited Business Overview
7.17.3 Hutchison MediPharma Limited Follicular Lymphoma Treatment Major Product Offerings
7.17.4 Hutchison MediPharma Limited Follicular Lymphoma Treatment Revenue in Global Market (2017-2022)
7.17.5 Hutchison MediPharma Limited Key News
7.18 Immune Design Corp.
7.18.1 Immune Design Corp. Corporate Summary
7.18.2 Immune Design Corp. Business Overview
7.18.3 Immune Design Corp. Follicular Lymphoma Treatment Major Product Offerings
7.18.4 Immune Design Corp. Follicular Lymphoma Treatment Revenue in Global Market (2017-2022)
7.18.5 Immune Design Corp. Key News
7.19 ImmunoGen, Inc.
7.19.1 ImmunoGen, Inc. Corporate Summary
7.19.2 ImmunoGen, Inc. Business Overview
7.19.3 ImmunoGen, Inc. Follicular Lymphoma Treatment Major Product Offerings
7.19.4 ImmunoGen, Inc. Follicular Lymphoma Treatment Revenue in Global Market (2017-2022)
7.19.5 ImmunoGen, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Follicular Lymphoma Treatment Market Opportunities & Trends in Global Market
Table 2. Follicular Lymphoma Treatment Market Drivers in Global Market
Table 3. Follicular Lymphoma Treatment Market Restraints in Global Market
Table 4. Key Players of Follicular Lymphoma Treatment in Global Market
Table 5. Top Follicular Lymphoma Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Follicular Lymphoma Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Follicular Lymphoma Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Follicular Lymphoma Treatment Product Type
Table 9. List of Global Tier 1 Follicular Lymphoma Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Follicular Lymphoma Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Follicular Lymphoma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Follicular Lymphoma Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Follicular Lymphoma Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Follicular Lymphoma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Follicular Lymphoma Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Follicular Lymphoma Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Follicular Lymphoma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Follicular Lymphoma Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Follicular Lymphoma Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Follicular Lymphoma Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Follicular Lymphoma Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Follicular Lymphoma Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Follicular Lymphoma Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Follicular Lymphoma Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Boehringer Ingelheim GmbH Corporate Summary
Table 31. Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Product Offerings
Table 32. Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Bristol-Myers Squibb Company Corporate Summary
Table 34. Bristol-Myers Squibb Company Follicular Lymphoma Treatment Product Offerings
Table 35. Bristol-Myers Squibb Company Follicular Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Celgene Corporation Corporate Summary
Table 37. Celgene Corporation Follicular Lymphoma Treatment Product Offerings
Table 38. Celgene Corporation Follicular Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Celldex Therapeutics, Inc. Corporate Summary
Table 40. Celldex Therapeutics, Inc. Follicular Lymphoma Treatment Product Offerings
Table 41. Celldex Therapeutics, Inc. Follicular Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Celltrion, Inc. Corporate Summary
Table 43. Celltrion, Inc. Follicular Lymphoma Treatment Product Offerings
Table 44. Celltrion, Inc. Follicular Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Cellular Biomedicine Group, Inc. Corporate Summary
Table 46. Cellular Biomedicine Group, Inc. Follicular Lymphoma Treatment Product Offerings
Table 47. Cellular Biomedicine Group, Inc. Follicular Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Coherus BioSciences, Inc. Corporate Summary
Table 49. Coherus BioSciences, Inc. Follicular Lymphoma Treatment Product Offerings
Table 50. Coherus BioSciences, Inc. Follicular Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 51. CTI BioPharma Corp. Corporate Summary
Table 52. CTI BioPharma Corp. Follicular Lymphoma Treatment Product Offerings
Table 53. CTI BioPharma Corp. Follicular Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Curis, Inc. Corporate Summary
Table 55. Curis, Inc. Follicular Lymphoma Treatment Product Offerings
Table 56. Curis, Inc. Follicular Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Dynavax Technologies Corporation Corporate Summary
Table 58. Dynavax Technologies Corporation Follicular Lymphoma Treatment Product Offerings
Table 59. Dynavax Technologies Corporation Follicular Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Eisai Corporate Summary
Table 61. Eisai Follicular Lymphoma Treatment Product Offerings
Table 62. Eisai Follicular Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 63. EpiZyme, Inc. Corporate Summary
Table 64. EpiZyme, Inc. Follicular Lymphoma Treatment Product Offerings
Table 65. EpiZyme, Inc. Follicular Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 66. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 67. F. Hoffmann-La Roche Ltd. Follicular Lymphoma Treatment Product Offerings
Table 68. F. Hoffmann-La Roche Ltd. Follicular Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Genentech, Inc. Corporate Summary
Table 70. Genentech, Inc. Follicular Lymphoma Treatment Product Offerings
Table 71. Genentech, Inc. Follicular Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Gilead Sciences, Inc. Corporate Summary
Table 73. Gilead Sciences, Inc. Follicular Lymphoma Treatment Product Offerings
Table 74. Gilead Sciences, Inc. Follicular Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 75. GlaxoSmithKline Plc Corporate Summary
Table 76. GlaxoSmithKline Plc Follicular Lymphoma Treatment Product Offerings
Table 77. GlaxoSmithKline Plc Follicular Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 78. Hutchison MediPharma Limited Corporate Summary
Table 79. Hutchison MediPharma Limited Follicular Lymphoma Treatment Product Offerings
Table 80. Hutchison MediPharma Limited Follicular Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 81. Immune Design Corp. Corporate Summary
Table 82. Immune Design Corp. Follicular Lymphoma Treatment Product Offerings
Table 83. Immune Design Corp. Follicular Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 84. ImmunoGen, Inc. Corporate Summary
Table 85. ImmunoGen, Inc. Follicular Lymphoma Treatment Product Offerings
Table 86. ImmunoGen, Inc. Follicular Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Follicular Lymphoma Treatment Segment by Type in 2021
Figure 2. Follicular Lymphoma Treatment Segment by Application in 2021
Figure 3. Global Follicular Lymphoma Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Follicular Lymphoma Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Follicular Lymphoma Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Follicular Lymphoma Treatment Revenue in 2021
Figure 8. By Type - Global Follicular Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Follicular Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Follicular Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Follicular Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 12. US Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Follicular Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Follicular Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 24. China Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Follicular Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Follicular Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Follicular Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bristol-Myers Squibb Company Follicular Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Celgene Corporation Follicular Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Celldex Therapeutics, Inc. Follicular Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Celltrion, Inc. Follicular Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Cellular Biomedicine Group, Inc. Follicular Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Coherus BioSciences, Inc. Follicular Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. CTI BioPharma Corp. Follicular Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Curis, Inc. Follicular Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Dynavax Technologies Corporation Follicular Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Eisai Follicular Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. EpiZyme, Inc. Follicular Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. F. Hoffmann-La Roche Ltd. Follicular Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Genentech, Inc. Follicular Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Gilead Sciences, Inc. Follicular Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. GlaxoSmithKline Plc Follicular Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Hutchison MediPharma Limited Follicular Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Immune Design Corp. Follicular Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. ImmunoGen, Inc. Follicular Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
